These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23583454)

  • 1. Substituted methcathinones differ in transporter and receptor interactions.
    Eshleman AJ; Wolfrum KM; Hatfield MG; Johnson RA; Murphy KV; Janowsky A
    Biochem Pharmacol; 2013 Jun; 85(12):1803-15. PubMed ID: 23583454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
    Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
    Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
    Maier J; Rauter L; Rudin D; Niello M; Holy M; Schmid D; Wilson J; Blough BE; Gannon BM; Murnane KS; Sitte HH
    Neuropharmacology; 2021 Jun; 190():108570. PubMed ID: 33864800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release.
    Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Swanson T; Johnson RA; Janowsky A
    J Pharmacol Exp Ther; 2017 Jan; 360(1):33-47. PubMed ID: 27799294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
    Halberstadt AL; Brandt SD; Walther D; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
    Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
    Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA
    Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
    J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.
    Blum K; Foster Olive M; Wang KK; Febo M; Borsten J; Giordano J; Hauser M; Gold MS
    Med Hypotheses; 2013 Sep; 81(3):450-5. PubMed ID: 23845561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.
    Cozzi NV; Brandt SD; Daley PF; Partilla JS; Rothman RB; Tulzer A; Sitte HH; Baumann MH
    Eur J Pharmacol; 2013 Jan; 699(1-3):180-7. PubMed ID: 23178523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.
    Janowsky A; Tosh DK; Eshleman AJ; Jacobson KA
    J Pharmacol Exp Ther; 2016 Apr; 357(1):24-35. PubMed ID: 26813929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.
    Severinsen K; Kraft JF; Koldsø H; Vinberg KA; Rothman RB; Partilla JS; Wiborg O; Blough B; Schiøtt B; Sinning S
    ACS Chem Neurosci; 2012 Sep; 3(9):693-705. PubMed ID: 23019496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.
    López-Arnau R; Martínez-Clemente J; Pubill D; Escubedo E; Camarasa J
    Br J Pharmacol; 2012 Sep; 167(2):407-20. PubMed ID: 22509960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV.
    Steele TWE; Spires Z; Jones CB; Glennon RA; Dukat M; Eltit JM
    Neuropharmacology; 2021 Dec; 200():108820. PubMed ID: 34619165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.
    Solis E
    Curr Top Behav Neurosci; 2017; 32():73-92. PubMed ID: 27677783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
    Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV
    Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
    Rickli A; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.
    Simmler LD; Rickli A; Hoener MC; Liechti ME
    Neuropharmacology; 2014 Apr; 79():152-60. PubMed ID: 24275046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.